UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection

International journal of molecular sciences, 2024-04, Vol.25 (7), p.3969

2024

Volltextzugriff (PDF)

Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes

Diabetes care, 2013-12, Vol.36 (12), p.3860-3862

2013

Volltextzugriff (PDF)

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

Diabetes therapy, 2020-09, Vol.11 (9), p.1909-1914

2020

Volltextzugriff (PDF)

Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort

Metabolism, clinical and experimental, 2017-05, Vol.70, p.42-50

2017

Volltextzugriff (PDF)

Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study

Diabetes therapy, 2021-02, Vol.12 (2), p.509-525

2021

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of basal insulins

Diabetes technology & therapeutics, 2011-06, Vol.13 Suppl 1 (S1), p.S15-S-24

2011

Volltextzugriff (PDF)

Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?

Biomolecules (Basel, Switzerland), 2021-08, Vol.11 (9), p.1281

2021

Volltextzugriff (PDF)

Renal function markers and insulin sensitivity after 3 years in a healthy cohort, the EGIR-RISC study

BMC nephrology, 2018-05, Vol.19 (1), p.124-124, Article 124

2018

Volltextzugriff (PDF)

Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People

Diabetes (New York, N.Y.), 2008-07, Vol.57 (7), p.1905-1917

2008

Volltextzugriff (PDF)

83-LB: Simplifying Insulin Treatment in Persons with T2 DM over 65 Years—Interim Report of the STOP Study

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways

Ageing research reviews, 2023-09, Vol.90, p.102018-102018, Article 102018

2023

Volltextzugriff (PDF)

Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin

Diabetes care, 2020-10, Vol.43 (10), p.2333-2335

2020

Volltextzugriff (PDF)

The physiological basis of insulin therapy in people with diabetes mellitus

Diabetes research and clinical practice, 2021-05, Vol.175, p.108839-108839, Article 108839

2021

Volltextzugriff (PDF)

Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans

Diabetes (New York, N.Y.), 2008-03, Vol.57 (3), p.746-756

2008

Volltextzugriff (PDF)

Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136

Diabetes care, 2021-03, Vol.44 (3), p.e59-e60

2021

Volltextzugriff (PDF)

Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes

Diabetes care, 2019-01, Vol.42 (1), p.85-92

2019

Volltextzugriff (PDF)

Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes

Advances in therapy, 2022-11, Vol.39 (11), p.4837-4846

2022

Volltextzugriff (PDF)

Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage

Diabetes (New York, N.Y.), 2023-10, Vol.72 (10), p.1364-1373

2023

Volltextzugriff (PDF)

Physical Activity and Insulin Sensitivity : The RISC Study

Diabetes (New York, N.Y.), 2008-10, Vol.57 (10), p.2613-2618

2008

Volltextzugriff (PDF)

Modification and Validation of the Triglyceride-to-HDL Cholesterol Ratio as a Surrogate of Insulin Sensitivity in White Juveniles and Adults without Diabetes Mellitus: The Single Point Insulin Sensitivity Estimator (SPISE)

Clinical chemistry (Baltimore, Md.), 2016-09, Vol.62 (9), p.1211-1219

2016

Volltextzugriff (PDF)

The role of gastric emptying in glucose homeostasis and defense against hypoglycemia: Innocent bystander or partner in crime?

Diabetes research and clinical practice, 2023-09, Vol.203, p.110828-110828, Article 110828

2023

Volltextzugriff (PDF)

Portal Vein Glucose Sensors Do Not Play a Major Role in Modulating Physiological Responses to Insulin-Induced Hypoglycemia in Humans

Diabetes (New York, N.Y.), 2009-01, Vol.58 (1), p.194-202

2009

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection

Diabetes care, 2015-12, Vol.38 (12), p.2204-2210

2015

Volltextzugriff (PDF)

One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs

Metabolism, clinical and experimental, 2022-01, Vol.126, p.154935-154935, Article 154935

2022

Volltextzugriff (PDF)

Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology

Current diabetes reports, 2018-10, Vol.18 (10), p.83-10, Article 83

2018

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(102)
Italienisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Humans
(49)
Endocrinology & Metabolism
(41)
Diabetes
(34)
Insulin
(32)
Male
(31)
Biological And Medical Sciences
(29)
Female
(29)
Medical Sciences
(26)
Adult
(23)
Blood Glucose - Metabolism
(22)
Hypoglycemia
(20)
Glucose
(19)
Middle Aged
(19)
Endocrinopathies
(17)
Diabetes Mellitus
(16)
Endocrine Pancreas. Apud Cells
(16)
Diabetes. Impaired Glucose Tolerance
(15)
Insulin - Blood
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection

Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort

Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study

Pharmacokinetics and pharmacodynamics of basal insulins

Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?

Renal function markers and insulin sensitivity after 3 years in a healthy cohort, the EGIR-RISC study

Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People

83-LB: Simplifying Insulin Treatment in Persons with T2 DM over 65 Years—Interim Report of the STOP Study

Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways

Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin

The physiological basis of insulin therapy in people with diabetes mellitus

Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans

Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136

Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes

Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes

Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage

Physical Activity and Insulin Sensitivity : The RISC Study

Modification and Validation of the Triglyceride-to-HDL Cholesterol Ratio as a Surrogate of Insulin Sensitivity in White Juveniles and Adults without Diabetes Mellitus: The Single Point Insulin Sensitivity Estimator (SPISE)

The role of gastric emptying in glucose homeostasis and defense against hypoglycemia: Innocent bystander or partner in crime?

Portal Vein Glucose Sensors Do Not Play a Major Role in Modulating Physiological Responses to Insulin-Induced Hypoglycemia in Humans

Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection

One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs

Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology

Suchergebnisse filtern